Liquid biopsies predict response to immunotherapy – Healio
Renal and Urology News |
Liquid biopsies predict response to immunotherapy
Healio “Immune checkpoint inhibitors, a class of immunotherapy, are transforming cancer treatment; however, overall only about 20% of patients respond to these drugs, and the drugs sometimes have significant side effects,” Razelle Kurzrock, MD, director of … Hypermutated ctDNA: A Marker of Checkpoint Inhibitor Response? |
